Amplia Therapeutics Ltd. (INNMF)

Amplia Therapeutics Ltd. (INNMF) Financial Statements


Amplia Therapeutics Ltd. Financial Overview

Amplia Therapeutics Ltd.'s market cap is currently ―. The company's EPS TTM is $-0.015; its P/E ratio is -3.14; Amplia Therapeutics Ltd. is scheduled to report earnings on May 27, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 22Mar 21Mar 20Mar 19Mar 18
Income Statement-
Total Revenue-----
Gross Profit-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 14.61MAU$ 1.85MAU$ 1.11MAU$ 1.24MAU$ 2.23M
Total AssetsAU$ 24.48MAU$ 10.88MAU$ 9.12MAU$ 9.19MAU$ 2.64M
Total DebtAU$ 2.10MAU$ 0.00AU$ 0.00AU$ 10.61KAU$ 0.00
Net DebtAU$ -12.51MAU$ -1.85MAU$ -1.11MAU$ -1.23MAU$ -2.23M
Total LiabilitiesAU$ 2.64MAU$ 539.13KAU$ 510.62KAU$ 526.86KAU$ 279.42K
Stockholders EquityAU$ 21.85MAU$ 10.34MAU$ 8.61MAU$ 8.66MAU$ 2.36M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in AUD

Amplia Therapeutics Ltd. Earnings and Revenue History

Amplia Therapeutics Ltd. Debt to Assets

Amplia Therapeutics Ltd. Cash Flow

Amplia Therapeutics Ltd. Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis